Facility (object) – Page 2 – Talk Bio

Actionable Insights Powered by AI

Amgen Expands in North Carolina with $1 Billion Biomanufacturing Facility

5 months ago talkbio0Tagged amgen, biomanufacturing, Drug Industry, expansion, Facility (object), North Carolina

Amgen, North Carolina, biomanufacturing, facility expansion, pharmaceutical industry

Johnson & Johnson Invests $2 Billion in New North Carolina Biologics Facility

7 months ago talkbio0Tagged Biological Factors, Facility (object), Investments, Johnson and Johnson, North Carolina, pharmaceutical manufacturing

Johnson & Johnson, North Carolina, Biologics Facility, Pharmaceutical Manufacturing, Investment

Theratechnologies Warns of Temporary Supply Disruption for EGRIFTA SV in Early 2025 Due to Third-Party Facility Shutdown

8 months ago talkbio0Tagged Disruption, Egrifta, Facility (object), HIV drug, shutdown, sievert, Theratechnologies

Theratechnologies, EGRIFTA SV, supply disruption, third-party facility shutdown, HIV drug, 2025

CDMO Serán Secures $200M Investment from Bain Capital to Establish First Commercial Facility

8 months ago talkbio0Tagged Bain Capital, Biopharmaceutical manufacturing, CDMO, commercial, Facility (object), Investments, Serán

CDMO Serán, Bain Capital, commercial facility, biopharmaceutical manufacturing, investment

Astellas Closes California Facility; Takeda Expands ADHD Drug Production Amid Generic Competition

8 months ago talkbio0Tagged Astellas, Attention deficit hyperactivity disorder, competition, Facility (object), Reparative closure, Takeda, Vyvanse

Astellas, Takeda, ADHD drug, Vyvanse, generic competition, facility closure

Pfizer Considers Facility Sale Amid GSK’s Administrative Breach in South Korea

9 months ago talkbio0Tagged administrative breach, Drug Industry, Facility (object), Pfizer, Sales - occupational activity, SmithKline Beecham, South Korea

Pfizer, facility sale, GSK, administrative breach, South Korea, pharmaceutical industry

Pfizer Expands API Manufacturing Site in Singapore with $740M+ Investment

10 months ago talkbio0Tagged alpha 1-antitrypsin, Extension, Facility (object), Investments, Manufacture, Pfizer, Singapore

Pfizer, API manufacturing, Singapore, facility extension, investment

EuroAPI to Cut 550 Jobs, Divest Facilities in Streamlining Plan to Reduce Reliance on Sanofi

11 months ago talkbio0Tagged Divestiture, EuroAPI, Facility (object), restructuring, sanofi

EuroAPI, job cuts, streamlining plan, Sanofi, facility divestiture, restructuring

Bionova Scientific Expands into Plasmid DNA Services for Cell and Gene Therapy Developers

11 months ago talkbio0Tagged Asahi Kasei, Biological Factors, Bionova, CDMO, Cells, DNA, Facility (object), gene therapy, Plasmids, Science, Texas

Bionova Scientific, Plasmid DNA, Cell and Gene Therapy, CDMO, Asahi Kasei Group, Biopharmaceuticals, Biologics, Texas Facility

Evotec Discontinues Gene Therapy Operations, Shuts Down Austria Facility

12 months ago talkbio0Tagged Austria, Biotechnology, business operations, development aspects, Evotec, Facility (object), gene therapy, Reparative closure, research, strategic decision

Evotec, gene therapy, Austria, facility closure, strategic decision, business operations, research and development, biotechnology